Forecasts by Product Type (Standard Pressurised Metered-Dose Inhalers, Pressurised Metered-dose Inhalers, Metered-Dose Inhaler with a Spacer, Dry Powder Inhalers, Soft Mist Inhalers, Others), by Drug Class (ICS, SABA+ICS, SABA, LABA, LAMA, ULABA, SABA+SAMA, LABA+LAMA+ICS, SAMA, Others), by Mode of Operation (Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices, Others), by Indication (Asthma, Chronic Obstructive Pulmonary Disease, Pulmonary Arterial Hypertension, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis
The Respiratory Inhalers Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Growing R&D Expenditure by Pharmaceutical and Biotechnology Companies Driving Market Growth As the demand for greater precision in drug delivery grows, respiratory inhaler devices, particularly among asthmatics and those suffering from chronic obstructive pulmonary disease, are becoming more popular. Because they have a decreased degree of immunity to chronic and pulmonary diseases, an increasing percentage of senior people utilise inhalers. Respiratory inhalers include complementary spacers or holding chambers to reduce the number of debris deposited in the mouth and throat. The market for respiratory products is expected to grow even more in light of the proposed shift to home healthcare.
One of the major digital platforms on which pharma and digital companies collaborate for the management of respiratory diseases is the smart inhaler market. In recent years, government organizations have been concerned about the rising death rates associated with respiratory diseases such as asthma and COPD. Government and regulatory agencies have implemented new guidelines in recent years that will significantly impact the market growth of smart inhalers. Increasing numbers of organizations are integrating digital technologies into their devices in an effort to improve medication management efficiency. The HeroTracker Sense application was launched by Aptar Pharma in April 2023, for example. Pressurized metered dose inhaler (pMDI) can now be converted into a smart connected health device through the use of this new digital respiratory health solution.
High Cost of Inhalers Likely to Challenge Market Growth Despite the increased prevalence of asthma worldwide, including in emerging markets such as Asia and developed areas such as North America, several barriers to the acceptance of these therapies exist. Inhalers are frequently regarded as the primary treatment for asthma, which is one of the major issues limiting market growth. According to the NCBI study, the CDC will spend approximately 49 billion in 2020, with Medicare covering only 51% of the COPD cost burden. As a result, the price of Advair, a critical asthma medication, has risen to US$648.8 in 2023, up from US$496.0 in 2013.
In addition to the high cost of drugs, underdiagnosis of asthma has been a key issue restricting market expansion. Asthma underdiagnosis leads to lower clinical outcomes for people who are unable to take the right asthma medicines to treat their medical condition. A lack of awareness and perception of asthma in the community, poor access to health care, strained health systems, the absence of diagnostic tests, including spirometry, a lack of training among health care providers, and a lack of non-implementation of asthma guidelines are all factors that contribute to underdiagnosis of asthma.
What Questions Should You Ask before Buying a Market Research Report? • How is the respiratory inhalers market evolving? • What is driving and restraining the respiratory inhalers market? • How will each respiratory inhalers submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033? • How will the market shares for each respiratory inhalers submarket develop from 2023 to 2033? • What will be the main driver for the overall market from 2023 to 2033? • Will leading respiratory inhalers markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others? • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033? • Who are the leading players and what are their prospects over the forecast period? • What are the respiratory inhalers projects for these leading companies? • How will the industry evolve during the period between 2023 and 2033? What are the implications of respiratory inhalers projects taking place now and over the next 10 years? • Is there a greater need for product commercialisation to further scale the respiratory inhalers market? • Where is the respiratory inhalers market heading and how can you ensure you are at the forefront of the market? • What are the best investment options for new product and service lines? • What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the respiratory inhalers market today, and over the next 10 years: • Our 354-page report provides 126 tables and 184 charts/graphs exclusively to you. • The report highlights key lucrative areas in the industry so you can target them – NOW. • It contains in-depth analysis of global, regional and national sales and growth. • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the respiratory inhalers market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares. • You will find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising respiratory inhalers prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Product Outlook • Standard Pressurized Metered-Dose Inhalers • Pressurized Metered-dose Inhalers (pMDI) • Metered-Dose Inhaler with a Spacer • Dry Powder Inhalers • Soft Mist Inhalers • Other Inhaler Type
Drug Class • ICS • SABA+ICS • SABA • LABA • LAMA • ULABA • SABA+SAMA • LABA+LAMA+ICS • SAMA • Other Class
Mode of Operation • Manually Operated Inhaler Devices • Digitally Operated Inhaler Devices • Other Mode Of Operation
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 18 leading national markets:
North America • U.S. • Canada
Europe • Germany • UK • France • Spain • Italy • Russia • Rest of Europe
Asia Pacific • China • Japan • India • Australia • South Korea • Rest of Asia Pacific
Latin America • Brazil • Mexico • Argentina • Rest of Latin America
The report also includes profiles and for some of the leading companies in the Respiratory Inhalers Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth • 3M Health Care • AptarGroup, Inc. • AstraZeneca • Boehringer Ingelheim International GmbH • Cipla Inc. • GF Health Products, Inc. • GSK plc • Koninklijke Philips N.V. • Medisana GmbH • Merck & Co., Inc. • Novartis AG • OMRON Corporation • Recipharm AB • Sunovion Pharmaceuticals Inc. • Teva Pharmaceutical Industries Ltd.
Overall world revenue for Respiratory Inhalers Market, 2023 to 2033 in terms of value the market will surpass US$45.0 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Respiratory Inhalers Market, 2023 to 2033 report help you? In summary, our 350+ page report provides you with the following knowledge:
• Revenue forecasts to 2033 for Respiratory Inhalers Market, 2023 to 2033 Market, with forecasts for product type, drug class, mode of operation, and indication, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 18 key national markets – See forecasts for the Respiratory Inhalers Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, LA, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 15 of the major companies involved in the Respiratory Inhalers Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Respiratory Inhalers Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
Buy our report today Respiratory Inhalers Market Report 2023-2033: Forecasts by Product Type (Standard Pressurised Metered-Dose Inhalers, Pressurised Metered-dose Inhalers, Metered-Dose Inhaler with a Spacer, Dry Powder Inhalers, Soft Mist Inhalers, Others), by Drug Class (ICS, SABA+ICS, SABA, LABA, LAMA, ULABA, SABA+SAMA, LABA+LAMA+ICS, SAMA, Others), by Mode of Operation (Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices, Others), by Indication (Asthma, Chronic Obstructive Pulmonary Disease, Pulmonary Arterial Hypertension, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1. Report Overview 1.1 Objectives of the Study 1.2 Introduction to Respiratory Inhalers Market 1.3 What This Report Delivers 1.4 Why You Should Read This Report 1.5 Key Questions Answered by This Analytical Report 1.6 Who is This Report for? 1.7 Methodology 1.7.1 Market Definitions 1.7.2 Market Evaluation & Forecasting Methodology 1.7.3 Data Validation 1.7.3.1 Primary Research 1.7.3.2 Secondary Research 1.8 Frequently Asked Questions (FAQs) 1.9 Associated Visiongain Reports 1.10 About Visiongain
2 Executive Summary
3 Market Overview 3.1 Key Findings 3.2 Market Dynamics 3.2.1 Market Driving Factors 3.2.1.1 Increasing Economic Burden of Asthma and Chronic Respiratory Diseases Will Increase Inhaler Demand 3.2.1.2 Inclusion of Inhalers on the WHO Essential Medicines List (EML) and National Reimbursement Lists (NRL) is a Milestone 3.2.1.3 Asthma as an NCD Priority Driving Demand for Inhalers 3.2.1.4 Increased Demand from Emerging Markets 3.2.1.5 The Pharmaceutical Industry is Embracing Digital Technologies to Combat Asthma 3.2.1.6 Improving Quality of Care Through Innovation 3.2.1.7 Increasing Awareness about Respiratory Drugs and Treatments 3.2.2 Market Restraining Factors 3.2.2.1 Inhalers Manufacturing Complications is Hindering the Growth 3.2.2.2 Market Growth Could Be Hindered by High Cost of Respiratory Medications 3.2.2.3 Respiratory Disease Research Efforts and Funding Are Not Aligned with the Relative Disability Related to Respiratory Diseases 3.2.2.4 Approval Process for New Respiratory Inhalers and Drugs is Overseen by Various Regulatory Bodies 3.2.3 Market Opportunities 3.2.3.1 Promising R&D Pipeline in the Respiratory Inhalers 3.2.3.2 An aging population that is prone to respiratory conditions is creating opportunities for manufacturers of inhalers 3.2.3.3 Affordable Care Act: Expanding Medicare Coverage 3.2.3.4 Both Innovator and Generic Products Have Met International Standards Creating Revenue Opportunities 3.2.4 Market Challenges 3.2.4.1 Asthma Inhalers Are Among the Most Complex Pharmaceutical Industry Manufactured Medical Devices in Widespread Use 3.2.4.2 Poor Treatment Adherence 3.2.4.3 Low-Income Countries Face Extra Challenges 3.2.4.4 Disruption of Clinical Trials Due to Pandemic Breakout 3.3 COVID-19 Impact Analysis 3.4 Porter’s Five Forces Analysis 3.4.1 Supplier Power 3.4.2 Buyer Power 3.4.3 Competitive Rivalry 3.4.4 Threat from Substitutes 3.4.5 Threat of New Entrants 3.5 PEST Analysis 3.5.1 Political Factors Impacting Respiratory Drug Delivery Technologies Market 3.5.2 Economic Factors Impacting Respiratory Drug Delivery Technologies Market 3.5.3 Social Factors Impacting Respiratory Drug Delivery Technologies Market 3.5.4 Technological Factors Impacting Respiratory Drug Delivery Technologies Market
4 Respiratory Inhalers Market Analysis by Product Type 4.1 Key Findings 4.2 Product Type Segment: Market Attractiveness Index 4.3 Respiratory Inhalers Market Share by Product Type, 2023 & 2033 4.4 Standard Metered-Dose Inhalers (Standard pMDIs) 4.4.1 Standard pMDIs Market Forecast by Region, 2023-2033 (US$ Bn) 4.4.2 Standard pMDIs Market Share by Region, 2023 & 2033 (%) 4.5 Pressurized Metered-dose Inhalers (pMDI) 4.5.1 pMDI Market Forecast by Region, 2023-2033 (US$ Bn) 4.5.2 pMDI Market Share by Region, 2023 & 2033 (%) 4.6 Metered-Dose Inhaler (MDI) with a Spacer 4.6.1 MDI With Spacer Market Forecast by Region, 2023-2033 (US$ Bn) 4.6.2 MDI With Spacer Market Share by Region, 2023 & 2033 (%) 4.7 Dry Powder Inhalers (DPI) 4.7.1 DPI Market Forecast by Region, 2023-2033 (US$ Bn) 4.7.2 DPI Market Share by Region, 2023 & 2033 (%) 4.8 Soft Mist Inhalers 4.8.1 Soft Mist Inhalers Market Forecast by Region, 2023-2033 (US$ Bn) 4.8.2 Soft Mist Inhalers Market Share by Region, 2023 & 2033 (%) 4.9 Other Inhalation Devices 4.9.1 Other Inhalation Devices Market Forecast by Region, 2023-2033 (US$ Bn) 4.9.2 Other Inhalation Devices Market Share by Region, 2023 & 2033 (%)
5 Respiratory Inhalers Market Analysis by Drug Class 5.1 Key Findings 5.2 Drug Class Segment: Market Attractiveness Index 5.3 Respiratory Inhalers Market Share by Drug Class, 2023 & 2033 5.4 Inhaled Corticosteroid (ICS) 5.4.1 ICS Market Forecast by Region, 2023-2033 (US$ Bn) 5.4.2 ICS Market Share by Region, 2023 & 2033 (%) 5.5 Short-acting beta-agonists (SABA)+ Inhaled Corticosteroid (ICS) 5.5.1 SABA+ICS Market Forecast by Region, 2023-2033 (US$ Bn) 5.5.2 SABA+ICS Market Share by Region, 2023 & 2033 (%) 5.6 Short-acting beta-agonists (SABA) 5.6.1 SABA Market Forecast by Region, 2023-2033 (US$ Bn) 5.6.2 SABA Market Share by Region, 2023 & 2033 (%) 5.7 Long-Acting Beta-Agonist (LABA) 5.7.1 LABA Market Forecast by Region, 2023-2033 (US$ Bn) 5.7.2 LABA Market Share by Region, 2023 & 2033 (%) 5.8 Long-acting muscarinic antagonists (LAMA) 5.8.1 LAMA Market Forecast by Region, 2023-2033 (US$ Bn) 5.8.2 LAMA Market Share by Region, 2023 & 2033 (%) 5.9 Ultra-Long-Acting β-Agonists (ULABA) 5.9.1 ULABA Market Forecast by Region, 2023-2033 (US$ Bn) 5.9.2 ULABA Market Share by Region, 2023 & 2033 (%) 5.10 Short-acting beta-agonists (SABA)+ Short-acting muscarinic-antagonist (SAMA) 5.10.1 SABA+SAMA Market Forecast by Region, 2023-2033 (US$ Bn) 5.10.2 SABA+SAMA Market Share by Region, 2023 & 2033 (%) 5.11 Long-Acting Beta-Agonist (LABA)+ Long-acting muscarinic antagonists (LAMA) + Inhaled Corticosteroid (ICS) 5.11.1 LABA+LAMA+ICS Market Forecast by Region, 2023-2033 (US$ Bn) 5.11.2 LABA+LAMA+ICS Market Share by Region, 2023 & 2033 (%) 5.12 Short-acting muscarinic-antagonist (SAMA) 5.12.1 SAMA Market Forecast by Region, 2023-2033 (US$ Bn) 5.12.2 SAMA Market Share by Region, 2023 & 2033 (%) 5.13 Other Class 5.13.1 Others Market Forecast by Region, 2023-2033 (US$ Bn) 5.13.2 Others Market Share by Region, 2023 & 2033 (%)
6 Respiratory Inhalers Market Analysis by Indication 6.1 Key Findings 6.2 Indication Segment: Market Attractiveness Index 6.3 Respiratory Inhalers Market Size Estimation and Forecast by Indication 6.4 Asthma 6.4.1 Asthma Market Forecast by Region, 2023-2033 (US$ Bn) 6.4.2 Asthma Market Share by Region, 2023-2033 (%) 6.5 Chronic Obstructive Pulmonary Disease (COPD) 6.5.1 COPD Market Forecast by Region, 2023-2033 (US$ Bn) 6.5.2 COPD Market Share by Region, 2023 & 2033 (%) 6.6 Pulmonary Arterial Hypertension 6.6.1 Pulmonary Arterial Hypertension Market Forecast by Region, 2023-2033 (US$ Bn) 6.6.2 Pulmonary Arterial Hypertension Market Share by Region, 2023 & 2033 (%) 6.7 Other Respiratory Diseases 6.7.1 Other Respiratory Diseases Market Forecast by Region, 2023-2033 (US$ Bn) 6.7.2 Other Respiratory Diseases Market Share by Region, 2023-2033 (%)
7 Respiratory Inhalers Market Analysis by Mode of Operation 7.1 Key Findings 7.2 Mode Of Operation Segment: Market Attractiveness Index 7.3 Respiratory Inhalers Market Share by Mode of Operation, 2023 & 2033 7.4 Manually Operated Inhaler Devices 7.4.1 Manually Operated Inhaler Devices Market Forecast by Region, 2023-2033 (US$ Bn) 7.4.2 Manually Operated Market Share by Region, 2023 & 2033 (%) 7.5 Digitally Operated Inhaler Devices 7.5.1 Digitally Operated Inhaler Devices Market Forecast by Region, 2023-2033 (US$ Bn) 7.5.2 Digitally Operated Inhaler Devices Market Share by Region, 2023 & 2033 (%) 7.6 Other Mode of Operation 7.6.1 Other Mode of Operation Market Forecast by Region, 2023-2033 (US$ Bn) 7.6.2 Other Mode of Operation Market Share by Region, 2023 & 2033 (%)
8 Respiratory Inhalers Market Analysis by Region 8.1 Key Findings 8.2 Regional Market Size Estimation and Forecast
9 North America Respiratory Inhalers Market Analysis 9.1 Key Findings 9.2 North America Respiratory Inhalers Market Attractiveness Index 9.3 North America Respiratory Inhalers Market by Country, 2023, 2028 & 2033 (US$ bn) 9.4 North America Respiratory Inhalers Market Size Estimation and Forecast by Country 9.5 North America Respiratory Inhalers Market Volume Estimation and Forecast by Country 9.6 North America Respiratory Inhalers Market Size Estimation and Forecast by Product Type 9.7 North America Respiratory Inhalers Market Size Estimation and Forecast by Drug Class 9.8 North America Respiratory Inhalers Market Size Estimation and Forecast by Mode of Operation 9.9 North America Respiratory Inhalers Market Size Estimation and Forecast by Indication 9.10 U.S. Respiratory Inhalers Market Analysis 9.11 Canada Respiratory Inhalers Market Analysis
10 Europe Respiratory Inhalers Market Analysis 10.1 Key Findings 10.2 Europe Respiratory Inhalers Market Attractiveness Index 10.3 Europe Respiratory Inhalers Market by Country, 2023, 2028 & 2033 (US$ bn) 10.4 Europe Respiratory Inhalers Market Size Estimation and Forecast by Country 10.5 Europe Respiratory Inhalers Market Volume Estimation and Forecast by Country 10.6 Europe Respiratory Inhalers Market Size Estimation and Forecast by Product Type 10.7 Europe Respiratory Inhalers Market Size Estimation and Forecast by Drug Class 10.8 Europe Respiratory Inhalers Market Size Estimation and Forecast by Mode of Operation 10.9 Europe Respiratory Inhalers Market Size Estimation and Forecast by Indication 10.10 Germany Respiratory Inhalers Market Analysis 10.11 UK Respiratory Inhalers Market Analysis 10.12 France Respiratory Inhalers Market Analysis 10.13 Italy Respiratory Inhalers Market Analysis 10.14 Spain Respiratory Inhalers Market Analysis 10.15 Russia Respiratory Inhalers Market Analysis 10.16 Rest of Europe Respiratory Inhalers Market Analysis
11 Asia Pacific Respiratory Inhalers Market Analysis 11.1 Key Findings 11.2 Asia Pacific Respiratory Inhalers Market Attractiveness Index 11.3 Asia Pacific Respiratory Inhalers Market by Country, 2023, 2028 & 2033 (US$ bn) 11.4 Asia Pacific Respiratory Inhalers Market Size Estimation and Forecast by Country 11.5 Asia Pacific Respiratory Inhalers Market Volume Estimation and Forecast by Country 11.6 Asia Pacific Respiratory Inhalers Market Size Estimation and Forecast by Product Type 11.7 Asia Pacific Respiratory Inhalers Market Size Estimation and Forecast by Drug Class 11.8 Asia Pacific Respiratory Inhalers Market Size Estimation and Forecast by Mode of Operation 11.9 Asia Pacific Respiratory Inhalers Market Size Estimation and Forecast by Indication 11.10 Japan Respiratory Inhalers Market Analysis 11.11 China Respiratory Inhalers Market Analysis 11.12 India Respiratory Inhalers Market Analysis 11.13 Australia Respiratory Inhalers Market Analysis 11.14 South Korea Respiratory Inhalers Market Analysis 11.15 Rest of Asia Pacific Respiratory Inhalers Market Analysis
12 Latin America Respiratory Inhalers Market Analysis 12.1 Key Findings 12.2 Latin America Respiratory Inhalers Market Attractiveness Index 12.3 Latin America Respiratory Inhalers Market by Country, 2023, 2028 & 2033 (US$ bn) 12.4 Latin America Respiratory Inhalers Market Size Estimation and Forecast by Country 12.5 Latin America Respiratory Inhalers Market Volume Estimation and Forecast by Country 12.6 Latin America Respiratory Inhalers Market Size Estimation and Forecast by Product Type 12.7 Latin America Respiratory Inhalers Market Size Estimation and Forecast by Drug Class 12.8 Latin America Respiratory Inhalers Market Size Estimation and Forecast by Mode of Operation 12.9 Latin America Respiratory Inhalers Market Size Estimation and Forecast by Indication 12.10 Brazil Respiratory Inhalers Market Analysis 12.11 Mexico Respiratory Inhalers Market Analysis 12.12 Argentina Respiratory Inhalers Market Analysis 12.13 Rest of Latin America Respiratory Inhalers Market Analysis
13 MEA Respiratory Inhalers Market Analysis 13.1 Key Findings 13.2 MEA Respiratory Inhalers Market Attractiveness Index 13.3 MEA Respiratory Inhalers Market by Country, 2023, 2028 & 2033 (US$ bn) 13.4 MEA Respiratory Inhalers Market Size Estimation and Forecast by Country 13.5 MEA Respiratory Inhalers Market Volume Estimation and Forecast by Country 13.6 MEA Respiratory Inhalers Market Size Estimation and Forecast by Product Type 13.7 MEA Respiratory Inhalers Market Size Estimation and Forecast by Drug Class 13.8 MEA Respiratory Inhalers Market Size Estimation and Forecast by Mode of Operation 13.9 MEA Respiratory Inhalers Market Size Estimation and Forecast by Indication 13.10 GCC Respiratory Inhalers Market Analysis 13.11 South Africa Respiratory Inhalers Market Analysis 13.12 Rest of MEA Respiratory Inhalers Market Analysis
14 Company Profiles 14.1 Company Share Analysis 14.2 Strategic Outlook 14.1 GSK plc 14.1.1 Company Snapshot 14.1.2 Company Overview 14.1.3 Financial Analysis 14.1.3.1 Net Revenue, 2017-2020 14.1.3.2 Regional Revenue/Market Shares, 2021 14.1.3.3 Segmental Revenue/Market Shares, 2021 14.1.4 Product Benchmarking 14.1.5 Strategic Outlook 14.2 Koninklijke Philips N.V. 14.2.1 Company Snapshot 14.2.2 Company Overview 14.2.3 Financial Analysis 14.2.3.1 Net Revenue, 2017-2021 14.2.3.2 Regional Revenue/Market Shares, 2021 14.2.3.3 Segmental Revenue/Market Shares, 2021 14.2.4 Product Benchmarking 14.2.5 Strategic Outlook 14.3 Boehringer Ingelheim International GmbH 14.3.1 Company Snapshot 14.3.2 Company Overview 14.3.3 Financial Analysis 14.3.3.1 Net Revenue, 2017-2021 14.3.3.2 Regional Revenue/Market Shares, 2021 14.3.3.3 Segmental Revenue/Market Shares, 2021 14.3.4 Product Benchmarking 14.3.5 Strategic Outlook 14.4 3M Health Care 14.4.1 Company Snapshot 14.4.2 Company Overview 14.4.3 Financial Analysis 14.4.3.1 Net Revenue, 2017-2021 10.2.1.1 Regional Revenue/Market Shares, 2021 10.2.1.2 Segmental Revenue/Market Shares, 2021 14.4.4 Product Benchmarking 14.4.5 Strategic Outlook 14.5 AstraZeneca 14.5.1 Company Snapshot 14.5.2 Company Overview 14.5.3 Financial Analysis 14.5.3.1 Net Revenue, 2017-2021 14.5.3.2 Regional Revenue/Market Shares, 2021 14.5.3.3 Segmental Revenue/Market Shares, 2021 14.5.4 Product Benchmarking 14.5.5 Strategic Outlook 14.6 Merck & Co., Inc. 14.6.1 Company Snapshot 14.6.2 Company Overview 14.6.3 Financial Analysis 14.6.3.1 Net Revenue, 2017-2021 14.6.3.2 Regional Revenue/Market Shares, 2021 14.6.3.3 Segmental Revenue/Market Shares, 2021 14.6.4 Product Benchmarking 14.6.5 Strategic Outlook 14.7 Novartis AG 14.7.1 Company Snapshot 14.7.2 Company Overview 14.7.3 Financial Analysis 14.7.3.1 Net Revenue, 2017-2021 14.7.3.2 Regional Revenue/Market Shares, 2021 14.7.3.3 Segmental Revenue/Market Shares, 2021 14.7.4 Product Benchmarking 14.7.5 Strategic Outlook 14.8 OMRON Corporation 14.8.1 Company Snapshot 14.8.2 Company Overview 14.8.3 Financial Analysis 14.8.3.1 Net Revenue, 2017-2021 14.8.3.2 Regional Revenue/Market Shares, 2021 14.8.3.3 Segmental Revenue/Market Shares, 2021 14.8.4 Product Benchmarking 14.8.5 Strategic Outlook 14.9 Sunovion Pharmaceuticals Inc. 14.9.1 Company Snapshot 14.9.2 Company Overview 14.9.3 Financial Analysis 14.9.3.1 Net Revenue, 2017-2021 14.9.3.2 Regional Revenue/Market Shares, 2021 14.9.4 Product Benchmarking 14.9.5 Strategic Outlook 14.10 Teva Pharmaceutical Industries Ltd. 14.10.1 Company Snapshot 14.10.2 Company Overview 14.10.3 Financial Analysis 14.10.3.1 Net Revenue, 2017-2021 14.10.3.2 Regional Revenue/Market Shares, 2021 14.10.4 Product Benchmarking 14.10.5 Strategic Outlook 14.11 Cipla Inc. 14.11.1 Company Snapshot 14.11.2 Company Overview 14.11.3 Financial Analysis 14.11.3.1 Net Revenue, 2017-2021 14.11.4 Product Benchmarking 14.11.5 Strategic Outlook 14.12 Recipharm AB 14.12.1 Company Snapshot 14.12.2 Company Overview 14.12.3 Financial Analysis 14.12.3.1 Net Revenue, 2017-2021 14.12.3.2 Regional Revenue/Market Shares, 2021 14.12.3.3 Segmental Revenue/Market Shares, 2021 14.12.4 Product Benchmarking 14.12.5 Strategic Outlook 14.13 Medisana GmbH 14.13.1 Company Snapshot 14.13.2 Company Overview 14.13.3 Product Benchmarking 14.14 GF Health Products, Inc. 14.14.1 Company Snapshot 14.14.2 Company Overview 14.14.3 Product Benchmarking 14.15 AptarGroup, Inc. 14.15.1 Company Snapshot 14.15.2 Company Overview 14.15.3 Financial Analysis 14.15.3.1 Net Revenue, 2017-2021 14.15.3.2 Regional Revenue/Market Shares, 2021 14.15.3.3 Segmental Revenue/Market Shares, 2021 14.15.4 Product Benchmarking 14.15.5 Strategic Outlook
15 Conclusion and Recommendations 15.1 Concluding Remarks from Visiongain 15.2 Recommendations for Market Players
List of Tables Table 1 Respiratory Inhalers Market Snapshot, 2023 & 2033 (US$ billion, CAGR %) Table 2 Respiratory Inhalers Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): “V” Shaped Recovery Scenario Table 3 Respiratory Inhalers Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): “U” Shaped Recovery Scenario Table 4 Respiratory Inhalers Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): “W” Shaped Recovery Scenario Table 5 Respiratory Inhalers Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): “L” Shaped Recovery Scenario Table 6 Standard pMDIs Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%) Table 7 Standard pMDIs Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%) Table 8 MDI with a Spacer Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%) Table 9 DPI Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%) Table 10 Soft Mist Inhalers Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%) Table 11 Other Inhalation Devices Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%) Table 12 ICS Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%) Table 13 SABA+ICS Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%) Table 14 SABA Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%) Table 15 LABA Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%) Table 16 LAMA Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%) Table 17 ULABA Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%) Table 18 SABA+SAMA Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%) Table 19 LABA+LAMA+ICS Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%) Table 20 SAMA Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%) Table 21 Others Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%) Table 22 Respiratory Inhalers Market Forecast by Indication, 2023-2033 (US$ bn, AGR%, CAGR%) Table 23 Cancer Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%) Table 24 COPD Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%) Table 25 Pulmonary Arterial Hypertension Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%) Table 26 Other Respiratory Diseases Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%) Table 27 Manually Operated Inhaler Devices Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%) Table 28 Digitally Operated Inhaler Devices Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%) Table 29 Other Mode Of Operation Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR%) Table 30 Respiratory Inhalers Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)) Table 31 North America Respiratory Inhalers Market Forecast by Country, 2023-2033 (US$ billion, AGR%, CAGR%) Table 32 North America Respiratory Inhalers Market Forecast by Country, 2023-2033 (Million Units, AGR%, CAGR%) Table 33 North America Respiratory Inhalers Market Forecast by Product Type, 2023-2033 (US$ billion, AGR%, CAGR%) Table 34 North America Respiratory Inhalers Market Forecast by Drug Class, 2023-2033 (US$ billion, AGR%, CAGR%) Table 35 North America Respiratory Inhalers Market Forecast by Mode Of Operation, 2023-2033 (US$ billion, AGR%, CAGR%) Table 36 North America Respiratory Inhalers Market Forecast by Indication, 2023-2033 (US$ billion, AGR%, CAGR%) Table 37 U.S. Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%) Table 38 Canada Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%) Table 39 Europe Respiratory Inhalers Market Forecast by Country, 2023-2033 (US$ billion, AGR%, CAGR%) Table 40 Europe Respiratory Inhalers Market Volume Forecast by Country, 2023-2033 (Unit Million, AGR%, CAGR%) Table 41 Europe Respiratory Inhalers Market Forecast by Product Type, 2023-2033 (US$ billion, AGR%, CAGR%) Table 42 Europe Respiratory Inhalers Market Forecast by Drug Class, 2023-2033 (US$ billion, AGR%, CAGR%) Table 43 Europe Respiratory Inhalers Market Forecast by Mode Of Operation, 2023-2033 (US$ billion, AGR%, CAGR%) Table 44 Europe Respiratory Inhalers Market Forecast by Indication, 2023-2033 (US$ billion, AGR%, CAGR%) Table 45 Germany Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%) Table 46 UK Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%) Table 47 France Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%) Table 48 Italy Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%) Table 49 Spain Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%) Table 50 Russia Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%) Table 51 Rest of Europe Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%) Table 52 Asia Pacific Respiratory Inhalers Market Forecast by Country, 2023-2033 (US$ billion, AGR%, CAGR%) Table 53 Asia Pacific Respiratory Inhalers Market Volume Forecast by Country, 2023-2033 (Unit Million, AGR%, CAGR%) Table 54 Asia Pacific Respiratory Inhalers Market Forecast by Product Type, 2023-2033 (US$ billion, AGR%, CAGR%) Table 55 Asia Pacific Respiratory Inhalers Market Forecast by Drug Class, 2023-2033 (US$ billion, AGR%, CAGR%) Table 56 Asia Pacific Respiratory Inhalers Market Forecast by Mode Of Operation, 2023-2033 (US$ billion, AGR%, CAGR%) Table 57 Asia Pacific Respiratory Inhalers Market Forecast by Indication, 2023-2033 (US$ billion, AGR%, CAGR%) Table 58 Japan Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%) Table 59 China Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%) Table 60 India Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%) Table 61 Australia Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%) Table 62 South Korea Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%) Table 63 Rest of Asia Pacific Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%) Table 64 Latin America Respiratory Inhalers Market Forecast by Country, 2023-2033 (US$ billion, AGR%, CAGR%) Table 65 Latin America Respiratory Inhalers Market Volume Forecast by Country, 2023-2033 (Unit Million, AGR%, CAGR%) Table 66 Latin America Respiratory Inhalers Market Forecast by Product Type, 2023-2033 (US$ billion, AGR%, CAGR%) Table 67 Latin America Respiratory Inhalers Market Forecast by Drug Class, 2023-2033 (US$ billion, AGR%, CAGR%) Table 68 Latin America Respiratory Inhalers Market Forecast by Mode Of Operation, 2023-2033 (US$ billion, AGR%, CAGR%) Table 69 Latin America Respiratory Inhalers Market Forecast by Indication, 2023-2033 (US$ billion, AGR%, CAGR%) Table 70 Brazil Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%) Table 71 Mexico Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%) Table 72 Argentina Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%) Table 73 Rest of Latin America Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%) Table 74 MEA Respiratory Inhalers Market Forecast by Country, 2023-2033 (US$ billion, AGR%, CAGR%) Table 75 MEA Respiratory Inhalers Market Volume Forecast by Country, 2023-2033 (Unit Million, AGR%, CAGR%) Table 76 MEA Respiratory Inhalers Market Forecast by Product Type, 2023-2033 (US$ billion, AGR%, CAGR%) Table 77 MEA Respiratory Inhalers Market Forecast by Drug Class, 2023-2033 (US$ billion, AGR%, CAGR%) Table 78 MEA Respiratory Inhalers Market Forecast by Mode Of Operation, 2023-2033 (US$ billion, AGR%, CAGR%) Table 79 MEA Respiratory Inhalers Market Forecast by Indication, 2023-2033 (US$ billion, AGR%, CAGR%) Table 80 GCC Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%) Table 81 South Africa Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%) Table 82 Rest of MEA Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%) Table 83 Respiratory Drug Delivery Technologies Market Strategic Outlook Table 84 GSK plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 85 GSK plc: Product Benchmarking Table 86 GSK plc: Strategic Outlook Table 87 Koninklijke Philips N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 88 Koninklijke Philips N.V.: Product Benchmarking Table 89 Koninklijke Philips N.V.: Strategic Outlook Table 90 Boehringer Ingelheim International GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 91 Boehringer Ingelheim International GmbH: Product Benchmarking Table 92 Boehringer Ingelheim International GmbH: Strategic Outlook Table 93 3M Health Care: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 94 3M Health Care: Product Benchmarking Table 95 3M Health Care: Strategic Outlook Table 96 AstraZeneca: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 97 AstraZeneca: Product Benchmarking Table 98 AstraZeneca: Strategic Outlook Table 99 Merck & Co., Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 100 Merck & Co., Inc: Product Benchmarking Table 101 Merck & Co., Inc: Strategic Outlook Table 102 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 103 Novartis AG.: Product Benchmarking Table 104 Novartis AG.: Strategic Outlook Table 105 OMRON Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 106 OMRON Corporation.: Product Benchmarking Table 107 OMRON Corporation.: Strategic Outlook Table 108 Sunovion Pharmaceuticals Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 109 Sunovion Pharmaceuticals Inc.: Product Benchmarking Table 110 Sunovion Pharmaceuticals Inc.: Strategic Outlook Table 111 Teva Pharmaceutical Industries Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 112 Teva Pharmaceutical Industries Ltd.: Product Benchmarking Table 113 Teva Pharmaceutical Industries Ltd.: Strategic Outlook Table 114 Cipla Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 115 Cipla Inc.: Product Benchmarking Table 116 Cipla Inc.: Strategic Outlook Table 117 Recipharm AB: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 118 Recipharm AB: Product Benchmarking Table 119 Recipharm AB: Strategic Outlook Table 120 Medisana GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 121 Medisana GmbH: Product Benchmarking Table 122 GF Health Products, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 123 GF Health Products, Inc.: Product Benchmarking Table 124 AptarGroup, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 125 AptarGroup, Inc.: Product Benchmarking Table 126 AptarGroup, Inc.: Strategic Outlook
List of Figures Figure 1 Respiratory Inhalers Market Segmentation Figure 2 Respiratory Inhalers Market by Indication: Market Attractiveness Index Figure 3 Respiratory Inhalers Market by Mode of Operation: Market Attractiveness Index Figure 4 Respiratory Inhalers Market by Type: Market Attractiveness Index Figure 5 Respiratory Inhalers Market by Drug Class: Market Attractiveness Index Figure 6 Respiratory Inhalers Market Forecast by Region: Market Attractiveness Index Figure 7 Respiratory Inhalers Market: Market Dynamics Figure 8 Product Pipeline Analysis Figure 9 Estimated Geriatric Population by Region in 2020 and by 2050 Figure 10 Respiratory Inhalers Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): “V” Shaped Recovery Figure 11 Respiratory Inhalers Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): “U” Shaped Recovery Figure 12 Respiratory Inhalers Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): “W” Shaped Recovery Figure 13 Respiratory Inhalers Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): “L” Shaped Recovery Figure 14 Respiratory Inhalers Market: Porter’s Five Forces Analysis Figure 15 Respiratory Inhalers Market: PESTLE Analysis Figure 16 Respiratory Inhalers Market Forecast by Product Type 2022, 2028, 2033 (Revenue, CAGR%) Figure 17 Respiratory Inhalers Market Share Forecast by Product Type, 2022, 2033 (%) Figure 18 Standard pMDIs Market Forecast by Region, 2023-2033 (US$ billion) Figure 19 Standard pMDIs Market Share Forecast by Region, 2023 & 2033 (%) Figure 20 pMDIs Market Forecast by Region, 2023-2033 (US$ billion) Figure 21 pMDIs Market Share Forecast by Region, 2023 & 2033 (%) Figure 22 MDI with a Spacer Market Forecast by Region, 2023-2033 (US$ billion) Figure 23 MDI with a Spacer Market Share Forecast by Region, 2023 & 2033 (%) Figure 24 DPI Market Forecast by Region, 2023-2033 (US$ billion) Figure 25 DPI Market Share Forecast by Region, 2023 & 2033 (%) Figure 26 Soft Mist Inhalers Market Forecast by Region, 2023-2033 (US$ billion) Figure 27 Soft Mist Inhalers Market Share Forecast by Region, 2023 & 2033 (%) Figure 28 Other Inhalation Devices Market Forecast by Region, 2023-2033 (US$ billion) Figure 29 Other Inhalation Devices Market Share Forecast by Region, 2023 & 2033 (%) Figure 30 Respiratory Inhalers Market Forecast by Drug Class 2022, 2028, 2033 (Revenue, CAGR%) Figure 31 Respiratory Inhalers Market Share Forecast by Drug Class, 2022 & 2033 (%) Figure 32 ICS Market Forecast by Region, 2023-2033 (US$ billion) Figure 33 ICS Market Share Forecast by Region, 2023 & 2033 (%) Figure 34 SABA+ICS Market Forecast by Region, 2023-2033 (US$ billion) Figure 35 SABA+ICS Market Share Forecast by Region, 2023 & 2033 (%) Figure 36 SABA Market Forecast by Region, 2023-2033 (US$ billion) Figure 37 SABA Market Share Forecast by Region, 2023 & 2033 (%) Figure 38 LABA Market Forecast by Region, 2023-2033 (US$ billion) Figure 39 LABA Market Share Forecast by Region, 2023 & 2033 (%) Figure 40 LAMA Market Forecast by Region, 2023-2033 (US$ billion) Figure 41 LAMA Market Share Forecast by Region, 2023 & 2033 (%) Figure 42 ULABA Market Forecast by Region, 2023-2033 (US$ billion) Figure 43 ULABA Market Share Forecast by Region, 2023 & 2033 (%) Figure 44 SABA+SAMA Market Forecast by Region, 2023-2033 (US$ billion) Figure 45 SABA+SAMA Market Share Forecast by Region, 2023 & 2033 (%) Figure 46 LABA+LAMA+ICS Market Forecast by Region, 2023-2033 (US$ billion) Figure 47 LABA+LAMA+ICS Market Share Forecast by Region, 2023 & 2033 (%) Figure 48 SAMA Market Forecast by Region, 2023-2033 (US$ billion) Figure 49 SAMA Market Share Forecast by Region, 2023 & 2033 (%) Figure 50 Others Market Forecast by Region, 2023-2033 (US$ billion) Figure 51 Others Market Share Forecast by Region, 2023 & 2033 (%) Figure 52 Respiratory Inhalers Market Forecast by Indication 2022, 2028, 2033 (Revenue, CAGR%) Figure 53 Respiratory Inhalers Market Forecast by Indication, 2023-2033 (US$ billion) Figure 54 Respiratory Inhalers Market Share Forecast by Indication, 2023, 2028, 2033 (%) Figure 55 Asthma Market Forecast by Region, 2023-2033 (US$ billion) Figure 56 Asthma Market Share Forecast by Region, 2022 & 2032 (%) Figure 57 COPD Market Forecast by Region, 2023-2033 (US$ billion) Figure 58 Cardiovascular Market Share Forecast by Region, 2023 & 2033 (%) Figure 59 Pulmonary Arterial Hypertension Market Forecast by Region, 2023-2033 (US$ billion) Figure 60 Pulmonary Arterial Hypertension Market Share Forecast by Region, 2023 & 2033 (%) Figure 61 Other Respiratory Diseases Market Forecast by Region, 2023-2033 (US$ billion) Figure 62 Other Respiratory Diseases Market Share Forecast by Region, 2023-2033 (%) Figure 63 Respiratory Inhalers Market Forecast by Mode of Operation 2022, 2028, 2033 (Revenue, CAGR%) Figure 64 Respiratory Inhalers Market Share Forecast by Mode Of Operation, 2022, 2033 (%) Figure 65 Manually Operated Inhaler Devices Market Forecast by Region, 2023-2033 (US$ billion) Figure 66 Cancer Market Share Forecast by Region, 2023 & 2033 (%) Figure 67 Digitally Operated Inhaler Devices Market Forecast by Region, 2023-2033 (US$ billion) Figure 68 Digitally Operated Inhaler Devices Market Share Forecast by Region, 2023 & 2033 (%) Figure 69 Other Mode Of Operation Market Forecast by Region, 2023-2033 (US$ billion) Figure 70 Other Mode Of Operation Market Share Forecast by Region, 2023 & 2033 (%) Figure 71 Respiratory Inhalers Market Forecast by Region 2022, 2023, 2028, 2033 (Revenue US$ Bn) Figure 72 Respiratory Inhalers Market Share Forecast by Region 2023, 2028, 2033(%) Figure 73 Respiratory Inhalers Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)) Figure 74 North America Respiratory Inhalers Market Attractiveness Index Figure 75 North America Respiratory Inhalers Market by Country, 2023, 2028 & 2033 (US$ billion) Figure 76 North America Respiratory Inhalers Market Forecast by Country, 2023-2033 (US$ billion) Figure 77 North America Respiratory Inhalers Market Share Forecast by Country, 2023 & 2033 (%) Figure 78 North America Respiratory Inhalers Market Forecast by Country, 2023-2033 (Million Units, AGR %) Figure 79 North America Respiratory Inhalers Market Forecast by Product Type, 2023-2033 (US$ billion) Figure 80 North America Respiratory Inhalers Market Share Forecast by Product Type, 2023 & 2033 (%) Figure 81 North America Respiratory Inhalers Market Forecast by Drug Class, 2023-2033 (US$ billion) Figure 82 North America Respiratory Inhalers Market Share Forecast by Drug Class, 2023 & 2033 (%) Figure 83 North America Respiratory Inhalers Market Forecast by Mode of Operation, 2023-2033 (US$ billion) Figure 84 North America Respiratory Inhalers Market Share Forecast by Mode of Operation, 2023 & 2033 (%) Figure 85 North America Respiratory Inhalers Market Forecast by Indication, 2023-2033 (US$ billion) Figure 86 North America Respiratory Inhalers Market Share Forecast by Indication, 2023 & 2033 (%) Figure 87 U.S. Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%) Figure 88 Canada Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%) Figure 89 Europe Respiratory Inhalers Market Attractiveness Index Figure 90 Europe Respiratory Inhalers Market by Region, 2023, 2028 & 2033 (US$ billion) Figure 91 Europe Respiratory Inhalers Market Forecast by Country, 2023-2033 (US$ billion) Figure 92 Europe Respiratory Inhalers Market Share Forecast by Country, 2023 & 2033 (%) Figure 93 Europe Respiratory Inhalers Market Volume Forecast by Country, 2023-2033 (Unit million) Figure 94 Europe Respiratory Inhalers Market Forecast by Product Type, 2023-2033 (US$ billion) Figure 95 Europe Respiratory Inhalers Market Share Forecast by Product Type, 2023 & 2033 (%) Figure 96 Europe Respiratory Inhalers Market Forecast by Drug Class, 2023-2033 (US$ billion) Figure 97 Europe Respiratory Inhalers Market Share Forecast by Drug Class, 2023 & 2033 (%) Figure 98 Europe Respiratory Inhalers Market Forecast by Mode of Operation, 2023-2033 (US$ billion) Figure 99 Europe Respiratory Inhalers Market Share Forecast by Mode of Operation, 2023 & 2033 (%) Figure 100 Europe Respiratory Inhalers Market Forecast by Indication, 2023-2033 (US$ billion) Figure 101 Europe Respiratory Inhalers Market Share Forecast by Indication, 2023 & 2033 (%) Figure 102 Germany Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%) Figure 103 UK Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%) Figure 104 France Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%) Figure 105 Italy Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%) Figure 106 Spain Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%) Figure 107 Russia Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%) Figure 108 Rest of Europe Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%) Figure 109 Asia Pacific Respiratory Inhalers Market Attractiveness Index Figure 110 Asia Pacific Respiratory Inhalers Market by Region, 2023, 2028 & 2033 (US$ billion) Figure 111 Asia Pacific Respiratory Inhalers Market Forecast by Country, 2023-2033 (US$ billion) Figure 112 Asia Pacific Respiratory Inhalers Market Share Forecast by Country, 2023 & 2033 (%) Figure 113 Asia Pacific Respiratory Inhalers Market Volume Forecast by Country, 2023-2033 (Unit million) Figure 114 Asia Pacific Respiratory Inhalers Market Forecast by Product Type, 2023-2033 (US$ billion) Figure 115 Asia Pacific Respiratory Inhalers Market Share Forecast by Product Type, 2023 & 2033 (%) Figure 116 Asia Pacific Respiratory Inhalers Market Forecast by Drug Class, 2023-2033 (US$ billion) Figure 117 Asia Pacific Respiratory Inhalers Market Share Forecast by Drug Class, 2023 & 2033 (%) Figure 118 Asia Pacific Respiratory Inhalers Market Forecast by Mode of Operation, 2023-2033 (US$ billion) Figure 119 Asia Pacific Respiratory Inhalers Market Share Forecast by Mode of Operation, 2023 & 2033 (%) Figure 120 Asia Pacific Respiratory Inhalers Market Forecast by Indication, 2023-2033 (US$ billion) Figure 121 Asia Pacific Respiratory Inhalers Market Share Forecast by Indication, 2023 & 2033 (%) Figure 122 Japan Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%) Figure 123 China Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%) Figure 124 India Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%) Figure 125 Australia Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%) Figure 126 South Korea Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%) Figure 127 Rest of Asia Pacific Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%) Figure 128 Latin America Respiratory Inhalers Market Attractiveness Index Figure 129 Latin America Respiratory Inhalers Market by Region, 2023, 2028 & 2033 (US$ billion) Figure 130 Latin America Respiratory Inhalers Market Forecast by Country, 2023-2033 (US$ billion) Figure 131 Latin America Respiratory Inhalers Market Share Forecast by Country, 2023 & 2033 (%) Figure 132 Latin America Respiratory Inhalers Market Volume Forecast by Country, 2023-2033 (Unit million, AGR %) Figure 133 Latin America Respiratory Inhalers Market Forecast by Product Type, 2023-2033 (US$ billion) Figure 134 Latin America Respiratory Inhalers Market Share Forecast by Product Type, 2023 & 2033 (%) Figure 135 Latin America Respiratory Inhalers Market Forecast by Drug Class, 2023-2033 (US$ billion) Figure 136 Latin America Respiratory Inhalers Market Share Forecast by Drug Class, 2023 & 2033 (%) Figure 137 Latin America Respiratory Inhalers Market Forecast by Mode of Operation, 2023-2033 (US$ billion) Figure 138 Latin America Respiratory Inhalers Market Share Forecast by Mode of Operation, 2023 & 2033 (%) Figure 139 Latin America Respiratory Inhalers Market Forecast by Indication, 2023-2033 (US$ billion) Figure 140 Latin America Respiratory Inhalers Market Share Forecast by Indication, 2023 & 2033 (%) Figure 141 Brazil Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%) Figure 142 Mexico Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%) Figure 143 Argentina Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%) Figure 144 Rest of Latin America Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%) Figure 145 MEA Respiratory Inhalers Market Attractiveness Index Figure 146 MEA Respiratory Inhalers Market by Region, 2023, 2028 & 2033 (US$ billion) Figure 147 MEA Respiratory Inhalers Market Forecast by Country, 2023-2033 (US$ billion) Figure 148 MEA Respiratory Inhalers Market Share Forecast by Country, 2023 & 2033 (%) Figure 149 MEA Respiratory Inhalers Market Volume Forecast by Country, 2023-2033 (Unit million) Figure 150 MEA Respiratory Inhalers Market Forecast by Product Type, 2023-2033 (US$ billion) Figure 151 MEA Respiratory Inhalers Market Share Forecast by Product Type, 2023 & 2033 (%) Figure 152 MEA Respiratory Inhalers Market Forecast by Drug Class, 2023-2033 (US$ billion) Figure 153 MEA Respiratory Inhalers Market Share Forecast by Drug Class, 2023 & 2033 (%) Figure 154 MEA Respiratory Inhalers Market Forecast by Mode of Operation, 2023-2033 (US$ billion) Figure 155 MEA Respiratory Inhalers Market Share Forecast by Mode of Operation, 2023 & 2033 (%) Figure 156 GCC Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%) Figure 157 South Africa Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%) Figure 158 Rest of MEA Respiratory Inhalers Market Forecast, 2023-2033 (US$ billion, AGR%) Figure 159 Respiratory Inhalers Market: Company Share Analysis, 2022 Figure 160 GSK plc: Net Revenue, 2017-2021 (US$ Million, AGR%) Figure 161 GSK plc: Regional Revenue Shares, 2021 Figure 162 GSK: Segmental Revenue Shares, 2021 Figure 163 Philips: Net Revenue, 2017-2021 (US$ Million, AGR%) Figure 164 Philips: Regional Revenue Shares, 2021 Figure 165 Philips: Segmental Revenue Shares, 2021 Figure 166 Boehringer Ingelheim International GmbH: Net Revenue, 2017-2021 (US$ Million, AGR%) Figure 167 Boehringer Ingelheim International GmbH: Regional Revenue Shares, 2021 Figure 171 AstraZeneca: Net Revenue, 2017-2021 (US$ billion, AGR%) Figure 172 AstraZeneca: Regional Revenue Shares, 2021 Figure 173 AstraZeneca: Segmental Revenue Shares, 2021 Figure 174 Merck & Co., Inc.: Net Revenue, 2017-2021 (US$ Million, AGR%) Figure 175 Merck & Co., Inc.: Regional Revenue Shares, 2021 Figure 176 Merck & Co., Inc.: Segmental Revenue Shares, 2021 Figure 177 Novartis AG: Net Revenue, 2017-2021 (US$ billion, AGR%) Figure 178 Novartis AG: Regional Revenue Shares, 2021 Figure 179 Novartis AG: Segmental Revenue Shares, 2021 Figure 183 Sunovion Pharmaceuticals Inc.: Net Revenue, 2017-2021 (US$ Million, AGR%) Figure 184 Sunovion Pharmaceuticals Inc.: Regional Revenue Shares, 2021
List of Companies Profiled in the Report 3M Health Care AptarGroup, Inc. AstraZeneca Boehringer Ingelheim International GmbH Cipla Inc. GF Health Products, Inc. GSK plc Koninklijke Philips N.V. Medisana GmbH Merck & Co., Inc. Novartis AG OMRON Corporation Recipharm AB Sunovion Pharmaceuticals Inc. Teva Pharmaceutical Industries Ltd.
List of Other Companies Mentioned in the Report 3P innovation Ltd (U.K.) Ab Initio Pharma Ltd (Australia) Berry Global Inc. (U.S.) Briggs of Burton Plc (UK) Catalent, Inc. (U.S.) CD Bioparticles (US) Celanese (U.S.) CF PharmTech, Inc. (China) Copley Scientific Limited (U.K.) Coster Tecnologie Speciali S.p.A (Italy) DFE Pharma (Germany) DH Industries Limited (UK) ELIX Polymers (Spain) Fluidda (Belgium) Gerresheimer Medical Systems (Germany) H&T Presspart (U.K.) HCmed Innovations Co., Ltd. (Taiwan) Hosokawa Micron Powder Systems (U.S.) Hovione (Portugal) Iconovo (Sweden) Inhalation Sciences (Sweden) Jabil Inc. (U.S.) Kenox Pharmaceuticals, Inc. (U.S.) Kindeva Drug Delivery Lab Automate Technologies Inc (U.S.) MEGGLE Group GmbH (Germany) MG America (U.S.) Micro-Sphere S.A. (Switzerland) Nemera (France) PARI GmbH (Germany) Teleflex Incorporated (U.S.) Wellbridge Biological Technology (China)
List of Associations Mentioned in the Report ACRF Centre for Advanced Respiratory Drug Delivery Technologies American Cancer Society (ACS) Agencia Nacional de Vigiloncia Sanitaria (ANVISA) Center for Biologics Evaluation and Research (CBER) Center for Devices and Radiological Health (CDRH) Center of Excellence in Cystic Fibrosis (CEI) Centers for Disease Control and Prevention (CDC) Centers for Medicare & Medicaid Services programs European Medicines Agency (EMA) European Union Food and Drug Administration (FDA) Government of Japan Health Ministry (Italy) Indian Council of Medical Research (ICMR) Institute for Healthcare Improvement (IHI) International Agency for Research on Cancer (IARC) Italian Industry Group Farmindustria Japanese Ministry of Health, Labour and Welfare Laboratory of Tumor Cystic Fibrosis and Biology at CCR Medicines and Healthcare Products Regulatory Agency (MHRA) Ministry of Health, Labour & Welfare (MHLW) National Cancer Institute (NCI) National Cancer Institute's Center for Cancer Research (CCR) National Development and Reform Commission (NDRC) National Institutes of Health (NIH) NCBI The Therapeutic Goods Administration United Nations (UN) University of Connecticut World Health Organization (WHO) World Population Prospects
Download sample pages
Complete the form below to download your free sample pages for Respiratory Inhalers Market Report 2023-2033
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
